ASX - Delayed Quote AUD
Mesoblast Limited (MSB.AX)
1.7300
-0.0700
(-3.89%)
At close: May 16 at 4:10:22 PM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-44,741
-48,458
-63,269
-65,782
--
Operating Cash Flow
--
-48,458
-63,269
-65,782
-100,749
Investing Cash Flow
53
-97
-194
-232
-1,647
Financing Cash Flow
41,534
40,252
74,502
-9,870
108,534
End Cash Position
50,023
62,960
71,318
60,447
136,881
Capital Expenditure
-185
-331
-314
-232
-1,647
Issuance of Capital Stock
65,406
65,406
88,635
209
106,268
Issuance of Debt
0
0
0
51,919
0
Repayment of Debt
--
-13,522
-2,656
-58,246
-2,931
Free Cash Flow
-44,926
-48,789
-63,583
-66,014
-102,396
6/30/2021 - 12/14/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BOT.AX Botanix Pharmaceuticals Limited
0.3850
+1.32%
CU6.AX Clarity Pharmaceuticals Ltd
2.5000
-0.79%
NEU.AX Neuren Pharmaceuticals Limited
13.19
+1.77%
CSL.AX CSL Limited
241.82
+1.44%
TLX.AX Telix Pharmaceuticals Limited
26.00
+3.42%
CUV.AX Clinuvel Pharmaceuticals Limited
10.71
-1.11%
NOX.AX Noxopharm Limited
0.0700
+4.48%
CYP.AX Cynata Therapeutics Limited
0.2000
+11.11%
DXB.AX Dimerix Limited
0.5950
+5.31%
OCC.AX Orthocell Limited
1.2750
-0.39%